AUROPHARMA taking support on monthly trend line and 20 dma

Aktualisiert
its attempt to cross target 1 getting rejected.
with no negative news
if crosses target 1 target 2 and target 3
possible.
Anmerkung
usa decision to reduce drug prices may have negative impact.
little bad news for pharma companies.
Chart PatternsTechnical IndicatorsTrend Analysis

Auch am:

Haftungsausschluss